|
Healing Touch and Immunity in Advanced Cervical Cancer Patients Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Healing Touch and Immunity in Advanced Cervical Cancer Patients conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Healing Touch and Immunity in Advanced Cervical Cancer Patients Clinical research trials and Healing Touch and Immunity in Advanced Cervical Cancer Patients health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Healing Touch and Immunity in Advanced Cervical Cancer Patients. Healing Touch and Immunity in Advanced Cervical Cancer Patients Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Healing Touch and Immunity in Advanced Cervical Cancer Patients clinical trial. Human subjects often get the best healthcare possible for their Healing Touch and Immunity in Advanced Cervical Cancer Patients condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > Healing Touch and Immunity in Advanced Cervical Cancer Patients  Healing Touch and Immunity in Advanced Cervical Cancer Patients
Healing Touch and Immunity in Advanced Cervical Cancer Patients
For Condition: Cervical Cancer
Status: Recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this study is to determine the effects of healing touch therapy on women with cancer who are undergoing chemotherapy and radiation.
Details: Healing touch (HT) is a therapy classified by NIH as a “biofield” therapy, as its effects are proposed to be the result of manipulation of hypothesized “energy fields” around the body of a patient. Although HT is frequently used as a complementary treatment by cancer patients undergoing chemotherapy and radiation to reduce toxic side effects of treatment and to maintain immunocompetence, effects of this treatment during cancer chemotherapy and radiation have not been investigated. Additionally, little is known about physiological mechanisms by which HT may work. A recent meta-analysis has demonstrated relatively large effects of HT on well-being and on physiological parameters, even from brief treatments. This study is designed to examine effects of HT on cellular immune function and short-term side effects of treatment among women with advanced cervical cancer who are receiving a standard 5-week course of external radiation therapy and concurrent chemotherapy. Although combined chemotherapy and radiation treatment is potentially curative in 69% of cases, many patients experience both acute and late side effects of radiation. Severe immune compromise has also been reported following intensive radiation. Identification of interventions that could reduce side effects and help maintain immunocompetence in advanced cervical cancer patients undergoing treatment is a critical health problem. There are no data on the effects of healing touch on immune function among cancer patients undergoing chemotherapy and radiation. Therefore this study is designed as an exploratory trial to determine whether such immune effects exist, and if so, what immune parameters are most likely to be affected. Effects of healing touch on mood and treatment-specific side-effects will also be examined. The significance of this study is that it will provide preliminary data on the impact, if any, of HT on various parameters of cellular immune function, beginning information on mechanisms of action, and whether the magnitude of the impact is large enough to be of sufficient clinical significance to be examined in larger clinical trials.
Eligibility:
Study Type: Interventional,Treatment,Randomized,Open Label,Active Control,Parallel Assignment,Efficacy Study
Minimum Age/Maximum Age: 18 Years/90 Years
Genders: Female
Protocol Entry Criteria: Inclusion Criteria: - Diagnosed with squamous or adenocarcinoma of stages Ib1 through IVa Exclusion Criteria: - Use of immunomodulating medications (eg. steroids) - Distant metastases
Total Enrollment: 64
Location and Contact Information:
University of Iowa *Recruiting*
Iowa City, Iowa, 52242
United States
Recruiting Heena Maiseri 319-335-0145
Additional Information:
Study ID Numbers: 1 P20 AT00756-01P4;
Study Start Date: August 2002
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00065091
Other Cervical Cancer Studies:
1. Epoetin beta in Treating Anemia in Patients With Cervical Cancer
2. Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
3. Healing Touch and Immunity in Advanced Cervical Cancer Patients
4. Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
5. SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
Related Studies:
Other Cervical Cancer Clinical Trials
Other Iowa Clinical Trials
Other Iowa City Clinical Trials
Healing Touch and Immunity in Advanced Cervical Cancer Patients
|
|
|
|
|
|
|
|
